Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin Once Daily in Acute Venous Thromboembolic Disease
NCT00265993Phase 4Completed
- Sponsor
- Sanofi
- Start
- Dec 2004
- Primary completion
- Jan 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of enoxaparin in deep vein thrombosis (DVT), pulmonary embolism (PE), sponsored by Sanofi. Started Dec 2004; status: completed.
02
Drugs
enoxaparin
03
Conditions
deep vein thrombosis (DVT)pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT00265993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00265993.